Patents by Inventor Michael P. Curtis

Michael P. Curtis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPLANT DEVICE, SYSTEM AND METHOD
    Publication number: 20240090889
    Abstract: An implant system includes an implant having a body having a proximal end, a distal end, a central cavity disposed between the proximal and distal end, and a proximal end opening disposed proximal to the central cavity. A toggle is at least partially housed within the central cavity and connected to the body by a toggle hinge connection, the toggle having a toggle lumen extending therethrough. An inserter includes an inserter lumen, and an actuator having a distal actuator tip configured to advance into the proximal end opening. An implant system, kit, method for placing an implant device, devices and systems using a pivot suture, suture loading device and related surgical procedures are also disclosed.
    Type: Application
    Filed: August 23, 2023
    Publication date: March 21, 2024
    Inventors: Robert P. Douglass, Miles O. Curtis, Saif Khalil, Paul M. Sethi, Nickolas G. Garbis, Michael C. Cusick, David L. Glaser
  • Endoparasitic depsipeptides
    Patent number: 11786575
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2, are as defined herein. The present invention also contemplates compositions and methods of treatment as an endoparasiticide with a Formula (1) compound.
    Type: Grant
    Filed: March 17, 2022
    Date of Patent: October 17, 2023
    Assignee: Zoetis Services LLC
    Inventors: Michael P. Curtis, Susan M. Sheehan, Graham M. Kyne, Matthew W. Bedore, Richard A. Ewin, Paul D. Johnson, Tom L. McTier, Christopher S Knauer, Rajendran Vairagoundar
  • Endoparasitic depsipeptides
    Patent number: 11771738
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2 are as defined herein. The present invention also contemplates compositions, methods of treatment, and uses as a medicament to treat an animal for an endoparasitic infection with a Formula (1) compound.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: October 3, 2023
    Assignee: Zoetis Services LLC
    Inventors: Todd Maddux, Matthew W. Bedore, Paul D. Johnson, Tomasz Respondek, Susan M. K. Sheehan, Graham M. Kyne, Richard A. Ewin, Rajendran Vairagoundar, Michael P. Curtis
  • Endoparasitic Depsipeptides
    Publication number: 20220323540
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2 are as defined herein. The present invention also contemplates compositions, methods of treatment, and uses as a medicament to treat an animal for an endoparasitic infection with a Formula (1) compound.
    Type: Application
    Filed: May 7, 2019
    Publication date: October 13, 2022
    Inventors: Todd Maddux, Matthew W. Bedore, Paul D. Johnson, Tomasz Respondek, Susan M.K. Sheehan, Graham M. Kyne, Richard A. Ewin, Rajendran Vairagoundar, Michael P. Curtis
  • Endoparasitic Depsipeptides
    Publication number: 20220211802
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2, are as defined herein. The present invention also contemplates compositions and methods of treatment as an endoparasiticide with a Formula (1) compound.
    Type: Application
    Filed: March 17, 2022
    Publication date: July 7, 2022
    Inventors: Michael P. Curtis, Susan M. Sheehan, Graham M. Kyne, Matthew W. Bedore, Richard A. Ewin, Paul D. Johnson, Tom L. McTier, Christopher S. Knauer, Rajendran Vairagoundar
  • Endoparasitic depsipeptides
    Patent number: 11331369
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2, are as defined herein. The present invention also contemplates compositions and methods of treatment as an endoparasiticide with a Formula (1) compound.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: May 17, 2022
    Assignee: Zoetis Services LLC
    Inventors: Michael P. Curtis, Susan M. Sheehan, Graham M. Kyne, Matthew W. Bedore, Richard A. Ewin, Paul D. Johnson, Tom L. McTier, Christoper S. Knauer, Rajendran Vairagoundar
  • Endoparasitic Depsipeptides
    Publication number: 20200282016
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2, are as defined herein. The present invention also contemplates compositions and methods of treatment as an endoparasiticide with a Formula (1) compound.
    Type: Application
    Filed: November 28, 2018
    Publication date: September 10, 2020
    Inventors: Michael P. Curtis, Susan M. Sheehan, Graham M. Kyne, Matthew W. Bedore, Richard A. Ewin, Paul D. Johnson, Tom L. McTier, Christoper S. Knauer, Rajendran Vairagoundar
  • Carboline antiparasitics
    Patent number: 10570129
    Abstract: The present invention provides Formula (1) compounds that are gamma-carbolines, Formula (1) wherein R1a, R1b, R1c, R1d, R2, R3, and “-” are as defined herein; veterinary acceptable salts thereof, and stereoisomers thereof, which act as parasiticides, in particular, endoparasiticides.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: February 25, 2020
    Assignee: Zoetis Services LLC
    Inventors: Govindan Subramanian, Michael P. Curtis, Jinxia (Nancy) Deng, Richard Andrew Ewin, Christopher Scott Knauer, Graham M. Kyne, Tomasz Respondek, Susan Mary Kult Sheehan, John Adam Wendt
  • CARBOLINE ANTIPARASITICS
    Publication number: 20200031822
    Abstract: The present invention provides Formula (1) compounds that are gamma-carbolines, Formula (1) wherein R1 a, R1 b, R1 c, R1d, R2, R3, and “-” are as defined herein; veterinary acceptable salts thereof, and stereoisomers thereof, which act as parasiticides, in particular, endoperasiticides.
    Type: Application
    Filed: June 10, 2016
    Publication date: January 30, 2020
    Applicant: Zoetis Services LLC
    Inventors: Govindan SUBRAMANIAN, Michael P. CURTIS, Jinxia (Nancy) DENG, Richard Andrew EWIN, Christopher Scott KNAUER, Graham M. KYNE, Tomasz RESPONDEK, Susan Mary Kult SHEEHAN, John Adam WENDT
  • Spiroindoline Antiparasitic Derivatives
    Publication number: 20160296499
    Abstract: The invention describes novel spiropiperidines of Formula (1A), (1B), and (1C) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, processes for making, and their use in animals as an antiparasitic. The variables A, R1, R2, R3, R4, v, m, 5, and n are as described herein.
    Type: Application
    Filed: December 22, 2014
    Publication date: October 13, 2016
    Inventors: John Adam Wendt, Mark Cox, Susan M.K. Sheehan, Michael P. Curtis, Tomasz Respondek, Richard Andrew Ewin, Graham M. Kyne, Paul D. Johnson
  • TRICYCLIC TETRAHYDROQUINOLINE ANTIBACTERIAL AGENTS
    Publication number: 20150111884
    Abstract: Described herein are antibacterial compounds of formula I, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections utilizing the compounds and pharmaceutical composition.
    Type: Application
    Filed: December 23, 2014
    Publication date: April 23, 2015
    Inventors: Michael P. Curtis, Timothy Allan Johnson, Manjinder S. Lall, Peter Laurence Toogood, Joseph S. Warmus
  • Bicyclic-substituted amines as histamine-3 receptor ligands
    Patent number: 8273767
    Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
    Type: Grant
    Filed: August 3, 2010
    Date of Patent: September 25, 2012
    Assignee: Abbott Laboratories
    Inventors: Robert J. Altenbach, Lawrence A. Black, Sou-Jen Chang, Marlon D. Cowart, Ramin Faghih, Gregory A. Gfesser, Yi-Yin Ku, Huaqing Liu, Kirill A. Lukin, Diana L. Nersesian, Yu-ming Pu, Padam N. Sharma, Youssef L. Bennani, Michael P. Curtis
  • Benzofuro- and benzothienopyrimidine modulators of the histamine Hreceptor
    Patent number: 8030321
    Abstract: Benzofuro- and benzothienopyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: October 4, 2011
    Assignee: Janssen Pharmaceutica, NV
    Inventors: Frank Chavez, Michael P. Curtis, James P. Edwards, Laurent Gomez, Cheryl A. Grice, Aaron M. Kearney, Brad M. Savall
  • BICYCLIC-SUBSTITUTED AMINES AS HISTAMINE-3 RECEPTOR LIGANDS
    Publication number: 20110098285
    Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
    Type: Application
    Filed: August 3, 2010
    Publication date: April 28, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Robert J. Altenbach, Lawrence A. Black, Sou-Jen Chang, Marlon D. Cowart, Ramin Faghih, Gregory A. Gfesser, Yi-Yin Ku, Huaqing Liu, Kirill A. Lukin, Diana L. Nersesian, Yu-ming Pu, Padam N. Sharma, Youssef L. Bennani, Michael P. Curtis
  • Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor
    Publication number: 20090325927
    Abstract: Benzofuro- and benzothienopyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
    Type: Application
    Filed: July 2, 2009
    Publication date: December 31, 2009
    Inventors: Frank Chavez, Michael P. Curtis, James P. Edwards, Laurent Gomez, Cheryl A. Grice, Aaron M. Kearney, Brad M. Savall
  • Benzofuro- and benzothienopyrimidine modulators of the histamine Hreceptor
    Patent number: 7576092
    Abstract: Benzofuro- and benzothienopyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: August 18, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Frank Chavez, Michael P. Curtis, James P. Edwards, Anne E. Fitzgerald, Laurent Gomez, Cheryl A. Grice, Aaron M. Kearney, Jing Liu, Neelakandha S. Mani, Brad M. Savall
  • SUBSTITUTED BENZYL AMINE COMPOUNDS
    Publication number: 20090137562
    Abstract: Certain substituted benzyl amine compounds are histamine H3 receptor and/or serotonin transporter modulators useful in the treatment of histamine H3 receptor- and/or serotonin-mediated diseases.
    Type: Application
    Filed: December 9, 2008
    Publication date: May 28, 2009
    Inventors: Brett Allison, Michael P. Curtis, Cheryl A. Grice, John M. Keith, Michael A. Letavic, Jennifer M.B. Miller, Emily M. Stocking
  • BICYCLIC-SUBSTITUTED AMINES AS HISTAMINE-3 RECEPTOR LIGANDS
    Publication number: 20090054420
    Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
    Type: Application
    Filed: August 21, 2008
    Publication date: February 26, 2009
    Applicant: ABBOTT LABORATORIES
    Inventors: Robert J. Altenbach, Lawrence A. Black, Sou-Jen Chang, Marlon D. Cowart, Ramin Faghih, Gregory A. Gfesser, Yi-Yin Ku, Huaqing Liu, Kirill A. Lukin, Diana L. Nersesian, Yu-ming Pu, Padam N. Sharma, Youssef L. Bennani, Michael P. Curtis
  • Substituted benzyl amine compounds
    Patent number: 7479493
    Abstract: Certain substituted benzyl amine compounds are histamine H3 receptor and/or serotonin transporter modulators useful in the treatment of histamine H3 receptor- and/or serotonin-mediated diseases.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: January 20, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Brett Allison, Michael P. Curtis, Cheryl A. Grice, John M. Keith, Michael A. Letavic, Jennifer M. B. Miller, Emily M. Stocking
  • SUBSTITUTED AMINOMETHYL BENZAMIDE COMPOUNDS
    Publication number: 20080045508
    Abstract: Certain substituted aminomethyl benzamide compounds are histamine H3 receptor and/or serotonin transporter modulators useful in the treatment of histamine H3 receptor- and/or serotonin-mediated diseases.
    Type: Application
    Filed: June 21, 2007
    Publication date: February 21, 2008
    Inventors: Brett Allison, Nicholas I. Carruthers, Michael P. Curtis, John M. Keith, Michael A. Letavic, Emily M. Stocking